You are here:


AOP Orphan Contact

AOP Orphan worldwide

Wilhelminenstraße 91/IIf
1160 Vienna, Austria
office(at)aoporphan.com

Current studies


Indication: patients with septic shock and persistent tachycardia
Study name: LANDI-SEP; EudraCT Nr 2017-002138-22

Indication: supraventricular tachycardia in pediatric patients
Study name: LANDI-PED; EudraCT Nr 2015-001129-17

Indication: Polycythemia Vera
Study name: CONTINUATION-PV; EudraCT Nr 2014-001357-17

  • An open-label, multicenter, phase IIIb study assessing the long-term efficacy and safety of AOP2014 and standard first line treatment (BAT) in patients with Polycythemia Vera who previously participated in the PROUD-PV study

  • Link to details on Clinicaltrials.gov